BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1970099)

  • 21. Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial.
    Anderson H; Scarffe JH; Sutton RN; Hickmott E; Brigden D; Burke C
    Br J Cancer; 1984 Jul; 50(1):45-9. PubMed ID: 6378236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir.
    Collins P; Oliver NM
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():103-12. PubMed ID: 3025149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.
    Anderson BJ; McGuire DP; Reed M; Foster M; Ortiz D
    Clin J Sport Med; 2016 Jul; 26(4):272-8. PubMed ID: 26540599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
    Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
    Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosing schedule of oral valacyclovir for prevention of herpes simplex virus.
    Moloney M; Prince HM; Seymour JF; Slavin M; Dooley M
    Bone Marrow Transplant; 2003 Nov; 32(10):1035. PubMed ID: 14595393
    [No Abstract]   [Full Text] [Related]  

  • 27. Acyclovir prophylaxis for herpes simplex virus infection.
    Goldberg LH; Sperber J
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1865. PubMed ID: 3435132
    [No Abstract]   [Full Text] [Related]  

  • 28. Valacyclovir to reduce transmission of genital herpes simplex virus infection.
    Drew WL
    J Infect Dis; 2009 Mar; 199(6):916. PubMed ID: 19239344
    [No Abstract]   [Full Text] [Related]  

  • 29. Extensive cutaneous involvement due to herpes simplex virus infection.
    Vilaça A; Pimentel T
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28601798
    [No Abstract]   [Full Text] [Related]  

  • 30. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections.
    Sauerbrei A; Wutzler P
    Med Microbiol Immunol; 2007 Jun; 196(2):89-94. PubMed ID: 17165093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acyclovir in pregnancy for primary prevention of neonatal herpes.
    Stiffman MN; Adam P
    J Fam Pract; 1997 Jan; 44(1):29-30. PubMed ID: 9010365
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of women at term with pregnancy complicated by herpes simplex.
    Forsgren M; Sterner G; Anzén B; Enocksson E
    Scand J Infect Dis Suppl; 1990; 71():58-66. PubMed ID: 2287918
    [No Abstract]   [Full Text] [Related]  

  • 34. Empiric acyclovir for neonatal herpes simplex virus infection.
    Vanderpluym C; Tawfik G; Hervas-Malo M; Lacaze-Masmonteil T; Kellner J; Robinson JL
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1278-82. PubMed ID: 21992471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal herpes simplex virus infections.
    Pinninti SG; Kimberlin DW
    Pediatr Clin North Am; 2013 Apr; 60(2):351-65. PubMed ID: 23481105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
    Wade JC; McLaren C; Meyers JD
    J Infect Dis; 1983 Dec; 148(6):1077-82. PubMed ID: 6317768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation.
    Patel D; Marchaim D; Marcus G; Gayathri R; Lephart PR; Lazarovitch T; Zaidenstein R; Chandrasekar P
    Clin Transplant; 2014 Jan; 28(1):1-5. PubMed ID: 24033498
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus.
    Simmons BP; Gelfand MS
    Infect Control; 1986 Jul; 7(7):380-3. PubMed ID: 3637170
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.